What is the safety of Tirofiban in Acute Ischemic Stroke?
The safety of Tirofiban in Acute Ischemic Stroke has been studied in several clinical trials. The SaTIS trial, the CLEAR stroke trial, and the AbESTT-II trial have all demonstrated the efficacy of Tirofiban for the treatment of acute ischemic stroke. Additionally, a case series study and a pilot safety study have both found that Tirofiban is safe and effective for the treatment of acute ischemic stroke in the short-term. Finally, a study on the use of Dabigatran therapy in acute ischemic stroke patients without atrial fibrillation found that Tirofiban was safe and effective in these patients as well. Overall, the evidence suggests that Tirofiban is a safe and effective treatment for acute ischemic stroke. 